Transarterial Ethanol Ablation for Unresectable Hepatocellular Carcinoma: Analysis of Clinical and Tumor Outcomes-Reference-Cited by-同舟云学术

Transarterial Ethanol Ablation for Unresectable Hepatocellular Carcinoma: Analysis of Clinical and Tumor Outcomes

Published:2016-05 Issue:5 Volume:27 Page:639-649
ISSN:1051-0443
Container-title:Journal of Vascular and Interventional Radiology
language:en
Short-container-title:Journal of Vascular and Interventional Radiology

Author:

Yu Simon Chun Ho,Hui Edwin Pun,Tang Peggy,Chan Stephen Ka Chi,Chu Charmant Cheuk Man,Hui Joyce Wai Yi,Chan Stephen Lam,Lee Kit Fai,Lai Paul Bo San,Yeo Winnie

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging

Reference20 articles.

1. Transarterial ethanol ablation of hepatocellular carcinoma with lipiodol ethanol mixture: phase II study;Yu;J Vasc Interv Radiol,2008

2. Embolization Efficacy and Treatment Effectiveness of Transarterial Therapy for Unresectable Hepatocellular Carcinoma: A Case-Controlled Comparison of Transarterial Ethanol Ablation with Lipiodol–Ethanol Mixture versus Transcatheter Arterial Chemoembolization

3. Unresectable hepatocellular carcinoma: randomized controlled trial of transarterial ethanol ablation versus transcatheter arterial chemoembolization;Yu;Radiology,2014

4. Surveillance: Epidemiology, and End Results (SEER) Program. SEER*Stat data-base: incidence—SEER 9 Regs research data. Nov 2014 Sub (1973-2007). Available at: www.seer.cancer.gov. Accessed December 29, 2015.

5. Transcatheter liver lobar ablation: an experimental trial in an animal model;Kan;Eur Radiol,1997

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Survival Outcomes in Transarterial Ethanol Ablation and Liver Resection for Solitary Hepatocellular Carcinoma ≤ 5 cm in Patients Stratified by Liver Function;CardioVascular and Interventional Radiology;2021-10-05

2. Comparison of Chemoembolization, Radioembolization, and Transarterial Ethanol Ablation for Huge Hepatocellular Carcinoma (≥ 10 cm) in Tumour Response and Long-Term Survival Outcome;CardioVascular and Interventional Radiology;2021-10-03

3. Management of arterial dissections in 12 patients during transarterial chemoembolization and yttrium-90 selective internal radiotherapy for primary and secondary liver tumours;Abdominal Radiology;2020-10-14

4. Individualized Ablation of Hepatocellular Carcinoma: Tailored Approaches across the Phenotype Spectrum;Seminars in Interventional Radiology;2019-10

5. Characterization of an Inducible Alcoholic Liver Fibrosis Model for Hepatocellular Carcinoma Investigation in a Transgenic Porcine Tumorigenic Platform;Journal of Vascular and Interventional Radiology;2018-08